Cantourage brings Ugandan medical cannabis to Germany through partnership with Israel’s Together Pharma

BERLIN – European medical cannabis leader Cantourage and Israeli medical cannabis producer Together Pharma (TASE: TGTR) have formed a partnership that will see the Ugandan medical cannabis brought to Germany. From today, pharmacies and patients throughout Germany will have access to two of Together Pharma’s THC genetics: Glueberry OG® and Power Plant.

– Partnership is a strong addition to Cantourage’s platform, which supplies wholesalers and pharmacies throughout Europe

The dried flower products are the first African medical cannabis products that Cantourage has made available in Germany. They will be distributed to pharmacies throughout the country in the coming weeks.

Together Pharma is the only cultivator of medical cannabis in Uganda. Its Ugandan farm extends over some approx. 30,000 sqm Greenhouses and has full production capacity of more than 15 tons annually, including a range of innovative cultivars which will be introduced to the European medical markets over the next months.

As of today, Cantourage has signed contracts with 18 leading cultivators from 13 different countries. Together Pharma is the first company that will launch products grown in Africa via Cantourage’s Fast Track Access Platform.

Philip Schetter, CEO of Cantourage, said: “With Together Pharma we are adding Uganda’s cultivator to Cantourage’s platform, supplying wholesalers and pharmacies throughout Europe. By bringing the first medical cannabis from Uganda to Germany we are adding even more treatment choice to patients and pharmacies, expanding our global network and highlighting our excellence at scouting the best growers globally. We feel privileged to be pioneers in bringing the best medical cannabis products from around the world into Germany at affordable prices for the benefit of patients.”

Nir Sosinsky, Managing Director of Together Pharma, added: “The partnership with Cantourage is extremely exciting for Together Pharma and a new stage in the expansion of our global reach and at the same time strengthens our commitment to Uganda’s cannabis industry, which holds great future potential for the country. Germany is an extremely important market for us and we are very glad to have launched our unique medical-grade cannabis buds for patients in Germany and, in the long term, the rest of Europe”.

(This information is primarily sourced from Cantourage.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).